Table 1 Overview of stakeholders, whether they were interviewed and their position on the bill
Stakeholders | Interviewed | Supporting | Opposing |
|---|---|---|---|
Political parties | |||
Liberal Alliance (LA)a | No | x | |
The Alternative (ALT) | No | x | |
The Conservative Party (KF)a | No | x | |
The Danish People’s Party (DF)a | No | x | |
The Danish Social Democrats (S)b | Noc | x | |
The Liberal Party (V)a | No | x | |
The Red-Green Alliance (EL) | No | x | |
The Socialist People’s Party (SF) | No | x | |
The Social Liberal Party (RV) | No | x | |
Public authorities | |||
The Ministry of Health (MH) | Yes | x | |
Organizations | |||
Danish Generic and Biosimilars Medicines Industry Association (IGL), ‘the generic industry’ | Yes | x | |
Danish Regions (DR) | No | x | |
Local Government (LG) | No | x | |
Pharmadanmark (PD)d | No | x | x |
The Association of Danish Pharmacies (ADP), ‘the pharmacy owners’ | Yes | x | |
The DaneAge (DAA) | No | x | |
The Danish Association of Pharmaconomists (DAP) | Yes | x | |
The Danish Association of the Pharmaceutical Industry (Lif), ‘the originator industry’ | Yes | x | |
The Danish Chamber of Commerce (DCoC) | Yes | x | |
The Danish Consumer Council (DCC), ‘the consumer organization’ | Yes | x | |
The Danish Medical Association (DMeA) | No | x | |
The Danish Nurses Organization (DNO) | No | x | |
The Danish Patient Association (DPA) | Noc | x | |
The Danish Patient Safety Association (DPSA) | No | x | |